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Abstract
Background: Trials of complex interventions are associated with high costs and burdens in terms of paperwork,
management, data collection, validation, and intervention fidelity assessment occurring across multiple sites.
Traditional data collection methods rely on paper-based forms, where processing can be time-consuming and error
rates high. Electronic source data collection can potentially address many of these inefficiencies, but has not
routinely been used in complex intervention trials. Here we present the use of an on-line system for managing all
aspects of data handling and for the monitoring of trial processes in a multicentre trial of a complex intervention.
We custom built a web-accessible software application for the delivery of ENGAGE-HD, a multicentre trial of a
complex physical therapy intervention. The software incorporated functionality for participant randomisation, data
collection and assessment of intervention fidelity. It was accessible to multiple users with differing levels of access
depending on required usage or to maintain blinding. Each site was supplied with a 4G-enabled iPad for accessing
the system. The impact of this system was quantified through review of data quality and collation of feedback from
site coordinators and assessors through structured process interviews.
Results: The custom-built system was an efficient tool for collecting data and managing trial processes. Although
the set-up time required was significant, using the system resulted in an overall data completion rate of 98.5% with
a data query rate of 0.1%, the majority of which were resolved in under a week. Feedback from research staff
indicated that the system was highly acceptable for use in a research environment. This was a reflection of the
portability and accessibility of the system when using the iPad and its usefulness in aiding accurate data collection,
intervention fidelity and general administration.
Conclusions: A combination of commercially available hardware and a bespoke online database designed to
support data collection, intervention fidelity and trial progress provides a viable option for streamlining trial
processes in a multicentre complex intervention trial. There is scope to further extend the system to cater for larger
trials and add further functionality such as automatic reporting facilities and participant management support.
Trial registration: ISRCTN65378754, registered on 13 March 2014.
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Background
Running a multicentre complex intervention trial generates
significant trial management demands both centrally and
in local teams independent of the complexity of the trial
design. Complex intervention trials are likely to require
data collection via multiple formats in order to monitor
and record multiple and differing aspects of the interven-
tion [1]. These may include the more traditional paper
Case Report Forms (CRFs), video observations and audio-
recordings, the latter usually requiring multiple pieces of
specialist equipment, all contributing to increased costs.
Complex interventions also require some degree of assess-
ment of how accurately the intervention is delivered to en-
sure consistency of delivery across multiple sites. Again
this can be costly in terms of personnel hours required and
can contribute to the general inefficiency of a trial.
Paper CRFs remain the most widely used data collection
tool and are perceived to be quick to implement and rela-
tively simple to manage [2]. Benefits of using paper CRFs
include the ease of testing, distribution to sites and simpli-
city at the point of study closure and archiving. However,
the need for transcription to electronic systems and/or
photocopying of paper CRFs for sending to the trial centre
is costly and introduces likely avenues for error and dupli-
cation of effort [3]. Further, lengthy monitoring visits may
be required to ensure the quality and appropriateness of
the data being collected, necessitating comparison of tran-
scribed records against the original source material. A move
to electronic source CRF (eSource) data collection provides
a method for reducing this burden. Initial set-up can be
time-consuming, however, and additional training is often
required for correct usage [3]. Currently, eSource data
collection has failed to replace traditional paper CRFs in
most complex intervention trial environments, although
the use of web-accessible data capture methods to improve
trial efficiency is an area of emerging interest.
Our aim was to use modern and portable eSource tech-
nologies to improve many of the management and data col-
lection errors and inefficiencies that are often experienced in
complex intervention trials, and to test this in a small-scale
study. ENGAGE-HD is a multicentre, single-blinded com-
plex intervention trial of a complex physical activity inter-
vention in Huntington’s disease where the intervention was
delivered at the participant’s home. Trial assessments were
performed over three time points at eight sites across the
UK [4] Although a relatively small trial, there were a num-
ber of specific complexities that made this a good case study
candidate for establishing proof of principle for such a sys-
tem: each site had a coordinator, one or more coaches for
the physical and social (control) intervention and assessors
blinded to the arm allocation of the participant. Briefly, site
coordinators scheduled appointments and visits, aided data
collection and acted as the main point of contact for the
Central Study Team. The blinded assessors conducted the
evaluations for the primary trial outcomes at three time
points in a hospital-based setting, with each assessment re-
quiring the completion of 9–15 individual CRFs. The inter-
vention coaches visited participants at their home on six
occasions between assessments 1 and 2 where they were re-
quired to deliver the intervention and collect weekly diary
data from participants. Therefore, data collection needed to
be as efficient as possible to maximise data capture across
all settings and time points. In this paper we describe the
system development, implementation and methods to cap-
ture impact of a custom-designed web-based system devel-
oped with the intention of streamlining trial processes in
ENGAGE-HD.
Methods
System development
The web-based system for ENGAGE-HD was designed to
be a robust, intuitive and flexible system with the primary
aim of aiding trial management and data collection. We in-
corporated a number of differing functional modules into
the system which provided a facility for monitoring and
assessing intervention fidelity and for performing the
randomisation of participants. Development took a period
of 3 months, encompassing alpha-testing, which focussed
on the initial look and feel of the system, and beta-testing
which focussed on the user acceptability of the system.
Development and testing was undertaken by an in-house
software developer at an approximate cost of £7250, with
data manager input at an approximate cost of approxi-
mately £9134 for the initial development. We estimate that
the developer provided maintenance and ongoing support
for 3 h over the duration of the recruitment period which
was an additional cost of £3782. This culminated in primar-
ily eSource data collection, with the option of using paper
CRFs where desired or required. All system users were
issued with their own username and password to access the
facility with differing levels of permissions conferred to
individual users dependent on their role. For example, the
blinding of assessors was maintained by denying them
access to participant allocation information and the inter-
vention coaches were given specific access to upload audio-
recordings to the database and to access a summary report
of the subsequent fidelity evaluation.
The platform was created to be accessible through
desktop computers and tablet devices to allow for maximum
functionality and real-time data capture. However, where
site staff felt more comfortable with completing paper CRFs,
the software was designed so that the CRF could be gener-
ated as a PDF directly from the platform and printed for
manual use. The software was also built to enable partici-
pant randomisation after the completion of the initial
assessment without the need to contact the Central Study
Team and also allowed for real-time data entry during home
visits and assessments. Randomisation was performed using
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minimisation [5] in order to balance between groups based
on data obtained at the baseline assessment (age, sex and
Unified Huntington’s Disease Rating Scale-Total Motor
Score (UHDRS-TMS).
The software added extra functionality as a data collection
tool with in-built data validation rules to minimise errors at
the point of data entry. With controllable format of data
entry fields, data could only be entered in the correct for-
mat, and values outside of prespecified ranges generated a
warning message to alert the researcher before the form
was saved. The system was also engineered with the cap-
ability to upload audio-recordings for fidelity assessment.
Intervention coaches could record the audio of their inter-
action with the participant using the iPad, which was then
securely uploaded to the database before being deleted ac-
cording to data protection strictures. The audio-recording
was rated for fidelity of the delivery of the intervention in
line with the theoretical framework on which it was devel-
oped [6]. Feedback from the intervention trainer was deliv-
ered to intervention coaches via Skype® on the tablet device.
The software design automatically stored inputted data in
a structured query language (SQL) database from which in-
terim extracts could be made available on demand. Further
design aspects enabled the Central Study Team to receive
e-mail alerts once assessment data had been submitted so
that data queries could be raised and resolved in a timely
fashion. Any changes made to the data forms after the
original submission were automatically saved, logging all
details required by Good Clinical Practice (GCP) require-
ments: the user who made the change, the date of the
change and the values before and after the change.
Device configuration
The web-based system was intended to be accessible to re-
searchers in real time so we decided to invest in portable,
web-enabled devices to make this possible. A number of
factors were considered in the choice of device to be used
in the trial. These ranged from availability, cost, portability
and security to the ease and acceptability of use in the trial
setting. We concluded that the device which would offer
the best compromise over all was the iPad Air® as it is a
widely used device, with uniform interface design across
most applications and would require the least amount of
additional training for users. The ability to use the video-
conferencing software Skype® and integrated video- and
audio-recording meant that a single device had all the re-
quired functionality to perform all trial-related tasks at site.
All devices were configured to use a secure Wi-Fi connec-
tion where available or to fall back on 4G data services,
which allowed reliable connectivity at all research sites.
Implementation
Prior to implementation at research sites, the system was
fully tested and validated using all devices and interfaces
that would be used as part of the trial. Each site was visited
by the Central Study Team for staff training in using the
iPad, uploading data through the website and the use of the
supplementary software packages. Checks were also carried
out on the availability of secure Wi-Fi access and cellular
network coverage. Each site was required to provide their
agreement to use the device and system as instructed and
to maintain device updates where necessary. Support and
additional training was also given through e-mail and tele-
phone contact with the trial manager on a needs basis.
Methods to capture impact
Our evaluation of the impact of the system was based
on two principal criteria: (1) trial data quality and (2)
user feedback. To assess data quality, we made a com-
parison of the number of data queries raised to the num-
ber of data items entered and the time taken to resolve
data queries. We also descriptively summarised the pro-
portion of missing data items in the minimum dataset.
We also noted how many sites were using paper CRFs
by the third and final participant assessment.
Feedback was obtained through structured telephone in-
terviews with members of research staff from across six of
the eight sites involved in the trial. We aimed to get feedback
from at least one person per site who had used the database.
We were able to conduct interviews with six members of site
staff which included: two intervention coaches, three site
coordinators (one of whom also acted as a coach) and one
blinded assessor. Interviews consisted of a predetermined set
of ten questions covering topics such as the usability and
accessibility of the system and support requirements. Inter-
views were conducted by the database developer and re-
sponses to questions were recorded verbatim in real time.
Responses were summarised according to the questions
asked using the method of qualitative description [7, 8].
Trial participants
Target recruitment for ENGAGE-HD inflated for losses to
follow-up was 62, requiring 46 for final analysis. Forty-six
participants were recruited (n = 25 male and n = 21 female).
Mean age was 59.4 years (standard deviation (SD) 10.1).
Results
Training and on-site support
The development of our bespoke, purpose-built electronic
trial management system required intensive resource in
the initial set-up period. Significant time was needed to
accurately write all the necessary metadata, which
included the use of in-built validation rules to prevent the
entry of erroneous data. Although not formally recorded,
we estimate that the development of the database required
12 weeks of data manager time and approximately 10
weeks of developer time, running concurrently, to build
and sufficiently test the system.
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The initial site set-up process required intensive training
during the initiation visit. In addition to standard site initi-
ation tasks, an extra 1–2 h was set aside to familiarise key
staff with the use of the iPad and the functions of the
ENGAGE-HD database. The requirement for additional
training differed between individual sites, based largely on
staff familiarity with using iPads or other electronic tablet
devices. Step-by-step guides were produced to help staff
with the use of additional applications required for audio-
and video-recording. Further support (via e-mails and
telephone calls) was also sometimes required during the
initial months after recruitment began until staff were suf-
ficiently confident with using the system.
Data quality
We evaluated the impact of the system on data collection
and quality by looking at the completeness and quality of
the data that was received through the database. Table 1
shows the number of completed electronic CRFs broken
down by individual study sites. Two sites achieved a com-
pletion rate of 100%, with the site returning the fewest
completed forms still achieving a completion rate of 96%.
Across the study, 2639 of 2678 CRFs were successfully
completed, giving an overall return rate of 98.5%. Individ-
ual sites were contacted for missing CRFs on multiple oc-
casions and this was monitored monthly by the Trial
Management Group. After a period of approximately 3
months, as none of the data contained in the missing
CRFs were critical for the primary trial analysis, the Trial
Management Committee decided to record this 1.5% of
nonreturned CRFs as missing data.
We were also able to assess the number of data queries
per site and the median time it took to resolve those data
issues. Overall there were 141 data queries for the whole
trial, which were resolved in a median time of 3 days
(Table 1). All but one site routinely resolved data queries
within 1 week of the query being raised. We calculated
that for participants in the physical intervention there
would be a total of 3134 data points across the whole trial
and 1674 for participants in the social arm. Assuming that
all participants completed the trial as intended and that all
CRFs were completed, this would give a total of over
100,000 individual data points. Therefore, the number of
data queries raised across the trial constitutes approxi-
mately 0.1% of all the data entered for the trial.
In order to assess fidelity, coaches in the intervention
arm were also asked to audio-record one of their home
visits, using an in-built iPad application and then upload
that file to the Central Study Team through the ENGAGE-
HD database. Sixteen participants completed the interven-
tion, and in all cases the coaches successfully uploaded an
audio-recording via the ENGAGE-HD database. Audio-
recordings captured by the iPad device were of sufficient
sound quality to be accurately transcribed, and formed the
basis of further fidelity analysis reported elsewhere [6].
Lastly, we reviewed the reported protocol deviations for
the trial to assess the impact of the database on protocol
adherence. Out of the 30 protocol deviations reported for
the ENGAGE-HD trial, three were related to the use of the
database. Two incidents could be attributed to user error:
the wrong age category was selected on the randomisation
form, and one audio-recording was not uploaded to the
database within 48 h of being taken so it could be deleted
from the iPad. The other incident was a case where the
blinded assessor had difficulty accessing the database and
was unable to upload the baseline information immedi-
ately. Although the data was recorded on back-up paper
copies, the process lead to a delay in the randomisation of
the participant so that they were not informed of their
group allocation until a number of days after the assess-
ment. The other incidences of protocol deviations were
largely attributed to scheduling issues or intrasite commu-
nications leading to the unblinding of assessors.
User impact
We considered the impact of the integrated system on both
the trial staff and the site staff. For trial staff, one of the major
advantages we found with using this system was that it
Table 1 Completion of electronic Case Report Forms (CRFs) and the number of data queries by study site
Study site Number of participants
recruited
Number of required
CRFs
Number of completed
CRFs
Completed CRFs
(% total)
Number of Data
queries
Median time to query
resolution (days)
1 10 654 643 98.3 22 4
2 2 124 120 96.8 6 1.5
3 4 239 237 99.2 22 1
4 5 325 325 100.0 18 1.5
5 6 337 337 100.0 22 6
6 4 241 240 99.6 8 19
7 10 576 563 97.7 18 2
8 5 182 174 96.0 25 2
Total 46 2678 2639 98.5 141 3
Drew et al. Trials  (2016) 17:551 Page 4 of 9
allowed real-time monitoring of the progress of the trial and
of individual participants. The database was programmed to
send e-mail alerts to the trial and data managers as soon as
participant assessment data had been entered. This enabled
prompt review of the data collected, allowing swift gener-
ation and resolution of data queries, as described above.
Further, this level of access allowed the Central Study Team
to monitor the progress of intervention visits and flag up if
there were any obvious delays. If such a problem was noted,
communication with the site could be initiated immediately
to offer further support and advice if required.
We performed semi-structured interviews with a mix of
site staff (n = 6) involved in ENGAGE-HD to investigate
their views on the impact of the database system on the
delivery of the study. A summary of the results from these
interviews can been in Table 2.
One interviewee was new to the collection of trial
data, but the remainder had performed similar work be-
fore and they all indicated that the majority of data col-
lection was using traditional paper CRFs. Three people
mentioned that data collected on paper CRFs was then
entered on to a database via a desktop PC and a further
person said that they had worked on studies previously
where data was uploaded directly into a database.
Half of the staff interviewed indicated that their experi-
ence of using iPads was limited and although the remainder
Table 2 Summary of feedback responses given by ENGAGE-HD research staff in semistructured interviews
Question Response Number of respondents
Have you previously collected
research data for studies?
If yes, how did you collect the data?
No 1
Yes, mainly using paper Case Report Forms (CRFs) 1
Yes, using paper CRFs then entered into a database 4
What was your experience of using
an iPad prior to your work on
ENGAGE-HD?
None 1
Limited 2
Personal use 4
What was your experience of using
an iPad on ENGAGE-HD?
Positive 6
What were some of the advantages? Mobility/ability to be able to work across NHS and other sites. 4
Ease of use 5
Facilitation of data entry 3
3G/Signal 2
In-built data validations 1
Ability to use additional apps 3
What were some of the disadvantages? None 1
System crashed once 1
Repeated log-ons (at each visit to the database web page)
slowed process
1
Only one device per site 1
Form design not optimum (for giving feedback and because
of repetitive data entry).
2
Poor battery life 1
Did you use the added functionality
of the iPad during the trial? If so how?
No 0
Yes Skype® 5
Camera for photographing documents 2
Audio-recording 4
Secure e-mail 2
Was the support you were given adequate? No 0
Yes 6
Has the use of the iPad on ENGAGE-HD
influenced your view on working with
it in clinical trials in future?
Not really 1
Yes Would use in future studies 3
A useful option 1
But might not work for all studies such as
text-heavy qualitative studies, etc.
1
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had experience through personal use, no one had previ-
ously used an iPad in a work context.
All respondents were extremely positive about the
training they received for using the iPad and database.
All respondents stated that the training and support they
received was adequate and no one had any suggestions
for improvements. Specific responses highlighted that
queries were responded to quickly, the standard operat-
ing procedures (SOPs) provided were clear and easy to
follow and that the site initiation training was good. Half
of the staff interviewed (n = 3) also singled out that effi-
cient management of the trial was important in how well
supported they felt.
To gain more specific perspectives of site staff, we
asked them to describe the relative advantages and dis-
advantages of fully eSource data collection using the
supplied iPad. The summary of responses can be found
in Table 2. These included benefits such as ease of use
and data collection, mobility of use and the ability to use
the additional apps to facilitate the work. Some of the
drawbacks mentioned included limited battery life, only
having one device per site, and that on-line forms could
be redesigned to allow more feedback.
All interviewees said that they took advantage of some
the additionally functionality (Skype®, audio-recording,
camera, e-mail) of using an iPad. The specific apps and
the amount they were used were dependent on the re-
search role of the specific interviewee. Intervention coa-
ches particularly liked the use of the audio-recording and
Skype® functions to discuss and receive feedback on the
delivery of the intervention with the intervention trainer.
Site coordinators employed the use of the camera to take
high-resolution images of documents which could then be
e-mailed securely to the coordinating centre.
Lastly, we asked the site staff if their experience of
using the iPad and database for ENGAGE-HD had influ-
enced their views on working on trials in the future. The
response to this was overwhelmingly positive, with the
move to paperless systems being particularly popular, al-
though it was noted that different studies would have
specific requirements.
Overall the feedback of the research staff interviewed on
the use of the iPad and database for delivering ENGAGE-
HD demonstrated high levels of acceptability to site users.
Discussion
Through this case study, we have demonstrated that is
possible to produce reliable, web-accessible software for
the purposes of data collection and management and
trial management in a multisite trial of a complex inter-
vention. The return rate and quality of data collected
was particularly high and the system had high user ac-
ceptability ratings. The use of the system also allowed
for efficient trial management by enabling sites to
perform randomisation of participants themselves and
by reducing the need for extensive and repeated on-site
data monitoring, which offset the initial intensive train-
ing required during site set-up.
The system we designed facilitated the immediate col-
lection of source data during study visits and assess-
ments via use of the iPad, negating the need for
secondary data transcription once it had been collected.
It seems likely that this portable collection facility, which
incorporated prompts and validation checks in real time,
ensured that the overall form completion rate for the
trial was high. Importantly, the software enabled the fa-
cility to provide paper back-ups of all CRFs when access
to the live system was not possible or desired and, as
such, data collection was not compromised.
Data validation rules that were embedded into the soft-
ware ensured that the accuracy of completed eSource data
was high, resulting in a low administrative burden in terms
of generating and resolving data queries. This specific data-
base design feature allowed us to be confident that when
assessment data had been entered and checked the data
was sufficiently clean for analysis, thereby negating the need
for lengthy data cleaning once the trial was finished. We
believe that this time-saving efficiency more than compen-
sated for the higher additional set-up time required for de-
veloping and programming the software. Additionally, the
combination of high levels of data completion and accuracy
along with the efficient site communication meant that in-
tensive site-monitoring visits were not deemed necessary to
ensure the efficient delivery of the trial.
The lack of multiple copies of paper CRFs in this trial
also conferred other benefits. Firstly, archiving at sites can
be problematic due to constraints on space in suitable fa-
cilities. The reduction in the volume of paperwork gener-
ated in ENGAGE-HD through the implementation of a
largely paperless system is, therefore, an important consid-
eration. Secondly, we were able to reduce the number of
costly site-monitoring visits, due to a decreased need to
carry out quality control inspections of paper records
against the transcribed copies on digital systems.
The use of this web-based system in ENGAGE-HD had
added benefits beyond data collection. The randomisation
was embedded in the programme ensuring that partici-
pants could be effectively randomised on the day of their
screening assessment without the need for contacting the
coordinating centre. This feature reduced the timelines of
progressing any given participant through the trial by re-
moving the need for staff at the sites and the coordinating
centre to communicate directly. Remote and automated
randomisation in itself is not novel and the approach has
been published elsewhere [9–11] as an effective method
for allocating participants, but to our knowledge it has not
previously been embedded within the study data collection
system alongside other trial-monitoring and management
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features. Perhaps, the most important design feature of the
ENGAGE-HD database was the integrated method for
fidelity monitoring, a vital aspect of delivering complex
interventions. This allowed rapid assessment of the fidelity
of the intervention delivery by all coaches with all partici-
pants in the physical intervention arm and for useful feed-
back to be delivered in a useful and timely fashion. For all
participants in the intervention arm, an audio-recording
was successfully uploaded for fidelity assessment, which
indicates the utility of the database for this process.
Additionally, the individualised permissions’ settings de-
signed for each user enabled intervention coaches to access
confidential feedback on their delivery of the intervention
through the system, which they could refer back to at any
time. We believe that this aspect of the system was key to
the high levels of intervention fidelity in the trial which we
have reported elsewhere [6].
It was important to gain the perspectives of end users
of the database who were not involved in its develop-
ment to determine the acceptability of the technology in
a research environment. If end users are not comfortable
or satisfied with the data collection and management
modules, they will either not engage with using the sys-
tem or, if enforced, their use maybe more inefficient and
less accurate. In general, the feedback we received from
site staff through the telephone interviews conducted
was positive and the move from paper CRF data collec-
tion to eSource was widely welcomed. Intervention coa-
ches were particularly receptive to the use of Skype® and
audio-recordings for fidelity monitoring and found the
feedback received useful for intervention delivery [6].
Some staff had reservations about using the iPad and
navigating the database whilst assessing participants, but
we found that additional support and training from the
coordinating centre alleviated these fears. Further, the
feedback that we received revealed that the additional
benefit of using an iPad on a cellular network was in
part that it was unaffected by many of the security fea-
tures present on NHS networks, which prevent the use
of some web-enable applications such as Skype®.
This case study provides preliminary indications that
our system was indeed beneficial to trial processes. We
do, however, acknowledge that our evaluation of impact
could have been strengthened by obtaining a wider
range of perspectives. A better approach would have
been to conduct face-to-face interviews with site staff ra-
ther than rely on a structured telephone interview.
We note that a major limitation in the evaluation of the
system as a whole is the lack of comparator (such as a
purely paper-based system), which is necessary to draw
firm conclusions about the efficiency of our system.
ENGAGE-HD was a feasibility trial of a complex interven-
tion and we did not plan to formally evaluate the efficacy
of our system in reducing data queries or data cleaning. In
spite of differential data query rates across our sites, the
overall data return rate across all ENGAGE-HD sites was,
however, similar. Furthermore the real-time monitoring of
data and in-built data validations to our system meant
that data cleaning occurred automatically. This suggests
that the system described here provides the added advan-
tage of site support during data collection but we are not
able to confirm this without a full-scale comparative
evaluation. We await, with interest, the results of the
TRANSFoRM study which is currently evaluating the util-
ity of an electronic platform in the recruitment and
follow-up of participants in primary care research [10] as
this is likely to provide more support for the approach we
describe here.
Whilst we found that the use of the on-line database
and portable technologies in the delivery of ENGAGE-HD
were largely beneficial, we recognise that this system had
limitations. In order for the system to be functional, inter-
net access is required at all times; therefore, secure Wi-Fi
or adequate cellular coverage must be available. We cir-
cumnavigated this issue by purchasing 4G-enabled tablet
devices, but recognise that this adds a significant extra
cost. Although lack of accessibility was an initial concern,
we resolved this by ensuring that paper copies could be
obtained without internet access. This ensured that acces-
sibility did not become an issue during the trial.
One of the aims of the ENGAGE-HD trial was to design
and implement an on-line system to streamline processes
associated with fidelity monitoring, participant randomisa-
tion, site communication and data collection in a multicen-
tre complex intervention trial. Electronic data capture is
becoming increasingly popular as a method of data acquisi-
tion in clinical trials for reducing both the time and costs
required to deliver a study [12, 13], but the number of stud-
ies using such applications remains comparatively small
[14]. Current methods of electronic data capture usually
require the transcription of paper records to eSource via
manual input or scanning technologies, both of which can
introduce error and a significant time burden on the re-
search team. With both of these methods, data still needs
to be checked for accuracy and validity, further adding to
trial running costs. Such processes contribute to general in-
efficiencies in trials where large amounts of data are being
collected [15]. Additional time-saving benefits of automated
trial processes and data collection compared to traditional
paper CRF methods and management are being increas-
ingly recognised in industry-sponsored trials [12, 16, 17].
For future versions of a similar trial database, we would
like to investigate the addition of further functional modules
that could further reduce time burdens in administration
and recording of necessary documentation. For example, we
found that although protocol deviations were reported in a
timely fashion, there were significant delays in receiving the
necessary signed documentation. We believe that by
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transferring this process to an on-line facility, documentation
would be completed in a more timely fashion. Similarly, we
would integrate screening logs and safety reporting into fu-
ture versions of the database to improve the speed of docu-
mentation return and improve consistency between sites.
In this trial we continued to monitor outcome data as it
was uploaded to check accuracy and completeness. As a re-
sult, future iterations should take further time during the
set-up period to add-in additional, stricter validation rules
or ‘flags’ for specific outcomes. A flagging system could be
incorporated so that data outside of accepted normative
values could produce a prompt to check the validity of the
data entered. Coupled with ‘free-text’ sections, where those
entering data could add further detail and explanation, this
would prevent largely erroneous data from being entered
and reduce the need for ‘by eye’ data monitoring. Further,
an investment in developing robust data validations at the
outset can be realised in subsequent trials where metadata
can be simply and reliably replicated.
Conclusions
Here we have demonstrated that the use of portable and
real-time technologies at the researcher-participant inter-
face in a multicentre complex intervention trial is a viable
and efficient method for improving trial management and
data collection procedures. There is scope to extend the
system further by adding other functional modules to aid in
other aspects of trial management. This includes schedule
planning, automatic compliance, safety reporting and dis-
semination of trial documentation updates. Although asses-
sing the validity of such a system in a larger-scale trial is
still required, the success of this system in ENGAGE-HD
has provided a basis for an accessible, secure platform for
the refinement and delivery of complex intervention trials.
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